ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.92
+0.08 (1.37%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ImageneBio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | 0.03 | -5.27 | 0.05 |
| Net Debt / Equity Ratio | -0.99 | 2.67 | -1.16 |
| Net Debt / EBITDA Ratio | 3.02 | 0.11 | 1.25 |
| Net Debt / FCF Ratio | 3.16 | 0.19 | 1.32 |
| Asset Turnover | - | 0.15 | - |
| Quick Ratio | 12.86 | 0.71 | 2.71 |
| Current Ratio | 13.24 | 0.73 | 2.73 |
| Return on Equity (ROE) | - | -373.35% | - |
| Return on Assets (ROA) | - | -98.06% | - |
| Return on Capital Employed (ROCE) | -30.80% | 2874.90% | -100.80% |
| Buyback Yield / Dilution | -22.59% | -21.97% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.